Retatrutide is an investigational synthetic peptide designed as a triple receptor agonist targeting GLP-1, GIP and glucagon receptors. It has been developed for research into metabolic signalling, energy regulation and glucose-related pathways. Laboratory and clinical research has explored its effects on multiple interconnected metabolic mechanisms and receptor pathways.
For laboratory research use only. Not for human or veterinary use.
Reviews
There are no reviews yet.